Emerging technologies that overcome biological barriers for therapeutic protein delivery.
In the past decade, genomic research and the nascent field of proteomics have exponentially increased the number of potential protein therapeutic molecules for treating medical needs that were previously unmet. To realise the full clinical potential of many of the novel protein drug entities arising from these intense research efforts, emerging protein delivery technologies may be required. Advanced delivery technologies may offer the ability to overcome biochemical and anatomical barriers to protein drug transport, without incurring adverse events, to deliver the agent(s) at a certain desired rate and duration, to protect therapeutic macromolecules from in situ or systemic degradation, as well as increase their therapeutic index by targeting the drug action to a specific site. This review will cover a myriad of novel and emerging technologies that are directed at bypassing biological barriers and that have shown promise in advancing the therapeutic potential of protein drugs.
D000279:Administration, Cutaneous; D000280:Administration, Inhalation; D000284:Administration, Oral; D000818:Animals; D015824:Blood-Air Barrier; D001812:Blood-Brain Barrier; D016503:Drug Delivery Systems; D006801:Humans; D017933:Peripheral Nervous System / Q000502:physiology; D011506:Proteins / Q000008:administration & dosage* / Q000627:therapeutic use*; D040901:Proteomics / Q000639:trends*
D011506:Proteins